These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32391255)

  • 61. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
    Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
    Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cognitive function before and after intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: a prospective study.
    Hsiao KY; Yeh SA; Chang CC; Tsai PC; Wu JM; Gau JS
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):722-6. PubMed ID: 20044217
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
    Kam MK; Chau RM; Suen J; Choi PH; Teo PM
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy.
    Chao HL; Liu SC; Tsao CC; Lin KT; Lee SP; Lo CH; Huang WY; Liu MY; Jen YM; Lin CS
    J Radiat Res; 2017 Sep; 58(5):654-660. PubMed ID: 28992206
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
    Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
    Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
    Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
    Huang XD; Li YC; Chen FP; Zheng WH; Zhou GQ; Lin L; Hu J; He WJ; Zhang LL; Kou J; Ma J; Zhang WD; Qi ZY; Sun Y
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):124-131. PubMed ID: 31075310
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma.
    Lee VH; Kwong DL; Leung TW; Choi CW; Lai V; Ng L; Lam KO; Ng SC; Sze CK; Tong CC; Ho PP; Chan WL; Wong LS; Leung DK; Chan SY; Khong PL
    Oncotarget; 2017 Jan; 8(3):5292-5308. PubMed ID: 28029657
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
    Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
    Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
    Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications.
    Lamiman K; Wong KK; Tamrazi B; Nosrati JD; Olch A; Chang EL; Kiehna EN
    Neurosurg Focus; 2016 Dec; 41(6):E15. PubMed ID: 27903114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Surgical management of radiation-induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: report of 14 cases.
    Mou YG; Sai K; Wang ZN; Zhang XH; Lu YC; Wei DN; Yang QY; Chen ZP
    Head Neck; 2011 Oct; 33(10):1493-500. PubMed ID: 21928423
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.
    Cheng JC; Chao KS; Low D
    Int J Cancer; 2001 Apr; 96(2):126-31. PubMed ID: 11291096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
    Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
    Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
    Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
    Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Mediating Role of Sleep Quality in the Association Between Negative Affect and Cognitive Function Among Patients With Nasopharyngeal Carcinoma After Intensity-Modulated Radiotherapy.
    Chen X; Fan Y; Yan M; Zhang JE
    Cancer Nurs; 2023 Apr; ():. PubMed ID: 37088890
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Asymptomatic Evolution and Regression of Temporal Lobe Necrosis After Adjuvant Radiation for Skin Cancer: A Case Report and Review of Literature.
    Pathak R; Bahl G
    Cureus; 2016 Feb; 8(2):e481. PubMed ID: 27226935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.